Onward Ho! Glenmark Strikes First Onco Asset Deal With China’s Harbour BioMed

 
• By Anju Ghangurde
Hand shaking
GLENMARK AND HARBOUR BIOMED HAVE FIRMED UP A LICENSING DEAL FOR AN ONCOLOGY ASSET

More from Deals

More from Business